Renaissance Technologies LLC grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 10.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 668,074 shares of the company’s stock after purchasing an additional 63,074 shares during the quarter. Renaissance Technologies LLC owned about 5.31% of U.S. Physical Therapy worth $40,352,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of USPH. Wells Fargo & Company MN increased its stake in shares of U.S. Physical Therapy by 5.5% in the 1st quarter. Wells Fargo & Company MN now owns 44,458 shares of the company’s stock worth $2,903,000 after acquiring an additional 2,335 shares in the last quarter. Great West Life Assurance Co. Can lifted its position in U.S. Physical Therapy by 6.4% in the 1st quarter. Great West Life Assurance Co. Can now owns 17,193 shares of the company’s stock valued at $1,122,000 after acquiring an additional 1,029 shares in the last quarter. First Trust Advisors LP lifted its position in U.S. Physical Therapy by 1.2% in the 1st quarter. First Trust Advisors LP now owns 23,246 shares of the company’s stock valued at $1,518,000 after acquiring an additional 281 shares in the last quarter. US Bancorp DE lifted its position in U.S. Physical Therapy by 6.9% in the 1st quarter. US Bancorp DE now owns 5,173 shares of the company’s stock valued at $338,000 after acquiring an additional 333 shares in the last quarter. Finally, Comerica Bank lifted its position in U.S. Physical Therapy by 3.7% in the 1st quarter. Comerica Bank now owns 13,814 shares of the company’s stock valued at $909,000 after acquiring an additional 496 shares in the last quarter. 94.95% of the stock is owned by hedge funds and other institutional investors.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 3,000 shares of the company’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $62.04, for a total value of $186,120.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Glenn Mcdowell sold 1,664 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $59.91, for a total transaction of $99,690.24. The disclosure for this sale can be found here. Insiders have sold a total of 13,266 shares of company stock valued at $801,134 over the last 90 days. 3.10% of the stock is currently owned by insiders.

USPH has been the topic of a number of recent analyst reports. BidaskClub raised shares of U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a report on Thursday, September 28th. Cantor Fitzgerald initiated coverage on U.S. Physical Therapy in a research note on Monday, July 24th. They issued an “overweight” rating and a $72.00 price target for the company. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 target price for the company in a research report on Tuesday, August 29th. Jefferies Group LLC set a $65.00 price target on U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, August 4th. Finally, Sidoti raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $62.00 to $74.00 in a research note on Friday, September 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $68.60.

TRADEMARK VIOLATION NOTICE: “Renaissance Technologies LLC Raises Holdings in U.S. Physical Therapy, Inc. (USPH)” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://www.watchlistnews.com/renaissance-technologies-llc-raises-holdings-in-u-s-physical-therapy-inc-usph/1605209.html.

U.S. Physical Therapy, Inc. (NYSE USPH) opened at 62.80 on Tuesday. U.S. Physical Therapy, Inc. has a 52-week low of $51.96 and a 52-week high of $78.00. The firm has a market capitalization of $790.09 million, a price-to-earnings ratio of 39.75 and a beta of 1.06. The company’s 50-day moving average is $59.45 and its 200-day moving average is $62.61.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.60 by ($0.01). U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. The business had revenue of $104.25 million during the quarter, compared to analysts’ expectations of $102.93 million. Equities analysts predict that U.S. Physical Therapy, Inc. will post $2.12 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 8th. Shareholders of record on Monday, August 21st were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, August 17th. This represents a $0.80 annualized dividend and a yield of 1.27%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 46.78%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.